-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for the flurbiprofen gel patch approved and issued by the State Drug Administration. Flubiprofen gel patch is a topical non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory effects. It is suitable for osteoarthritis, periodontitis, tendon and tenosynovitis, inflammation around the tendon sheath, lateral epicondylitis of the humerus (tennis elbow), muscle pain, and swelling and pain caused by trauma. This product is a Class B type of national medical insurance.

Zhitongcaijing·11/16/2026 08:49:03
Listen to the news
Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) issued an announcement. Recently, the company received the “Drug Registration Certificate” for the flurbiprofen gel patch approved and issued by the State Drug Administration. Flubiprofen gel patch is a topical non-steroidal anti-inflammatory drug with analgesic and anti-inflammatory effects. It is suitable for osteoarthritis, periodontitis, tendon and tenosynovitis, inflammation around the tendon sheath, lateral epicondylitis of the humerus (tennis elbow), muscle pain, and swelling and pain caused by trauma. This product is a Class B type of national medical insurance.